According to the results of gene expression, the carriers with at least one variant allele had decreased mRNA expression of PER1. The decreased expression level of PER1 was observed in breast cancer tissue and associated with worse breast cancer type ER-. This evidence concerns the gene PER1 and breast carcinoma.